183 related articles for article (PubMed ID: 31308388)
1. HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.
Nyanhete TE; Frisbee AL; Bradley T; Faison WJ; Robins E; Payne T; Freel SA; Sawant S; Weinhold KJ; Wiehe K; Haynes BF; Ferrari G; Li QJ; Moody MA; Tomaras GD
Sci Rep; 2019 Jul; 9(1):10165. PubMed ID: 31308388
[TBL] [Abstract][Full Text] [Related]
2. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
3. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
Ferre AL; Hunt PW; McConnell DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
J Virol; 2010 Nov; 84(21):11020-9. PubMed ID: 20719952
[TBL] [Abstract][Full Text] [Related]
4. Acute-Phase CD4
Sutton MS; Ellis-Connell A; Moriarty RV; Balgeman AJ; Gellerup D; Barry G; Weiler AM; Friedrich TC; O'Connor SL
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111562
[TBL] [Abstract][Full Text] [Related]
5. HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer
Laher F; Ranasinghe S; Porichis F; Mewalal N; Pretorius K; Ismail N; Buus S; Stryhn A; Carrington M; Walker BD; Ndung'u T; Ndhlovu ZM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077659
[TBL] [Abstract][Full Text] [Related]
6. Antiviral CD8
Ranasinghe S; Lamothe PA; Soghoian DZ; Kazer SW; Cole MB; Shalek AK; Yosef N; Jones RB; Donaghey F; Nwonu C; Jani P; Clayton GM; Crawford F; White J; Montoya A; Power K; Allen TM; Streeck H; Kaufmann DE; Picker LJ; Kappler JW; Walker BD
Immunity; 2016 Oct; 45(4):917-930. PubMed ID: 27760342
[TBL] [Abstract][Full Text] [Related]
7. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
8. Case report: mechanisms of HIV elite control in two African women.
Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune control.
Ranasinghe S; Cutler S; Davis I; Lu R; Soghoian DZ; Qi Y; Sidney J; Kranias G; Flanders MD; Lindqvist M; Kuhl B; Alter G; Deeks SG; Walker BD; Gao X; Sette A; Carrington M; Streeck H
Nat Med; 2013 Jul; 19(7):930-3. PubMed ID: 23793098
[TBL] [Abstract][Full Text] [Related]
10. HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.
Bansal A; Gehre MN; Qin K; Sterrett S; Ali A; Dang Y; Abraham S; Costanzo MC; Venegas LA; Tang J; Manjunath N; Brockman MA; Yang OO; Kan-Mitchell J; Goepfert PA
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228645
[TBL] [Abstract][Full Text] [Related]
11. Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.
Julg B; Moodley ES; Qi Y; Ramduth D; Reddy S; Mncube Z; Gao X; Goulder PJ; Detels R; Ndung'u T; Walker BD; Carrington M
J Infect Dis; 2011 Mar; 203(6):803-9. PubMed ID: 21257739
[TBL] [Abstract][Full Text] [Related]
12. HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.
Keane NM; Pavlos RK; McKinnon E; Lucas A; Rive C; Blyth CC; Dunn D; Lucas M; Mallal S; Phillips E
AIDS; 2014 Aug; 28(13):1891-901. PubMed ID: 24911354
[TBL] [Abstract][Full Text] [Related]
13. Role of class I major histocompatibility complex-restricted and -unrestricted suppression of human immunodeficiency virus type 1 replication by CD8+ T lymphocytes.
Ohashi T; Kubo M; Kato H; Iwamoto A; Takahashi H; Fujii M; Kannagi M
J Gen Virol; 1999 Jan; 80 ( Pt 1)():209-216. PubMed ID: 9934704
[TBL] [Abstract][Full Text] [Related]
14. A Novel Immunogen Selectively Eliciting CD8
Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the CD8
Killian MS; Teque F; Sudhagoni R
Immunogenetics; 2018 Feb; 70(2):99-113. PubMed ID: 28735348
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
[TBL] [Abstract][Full Text] [Related]
17. Impact of HLA-DRB1 allele polymorphisms on control of HIV infection in a Peruvian MSM cohort.
Oriol-Tordera B; Llano A; Ganoza C; Cate S; Hildebrand W; Sanchez J; Calle ML; Brander C; Olvera A
HLA; 2017 Oct; 90(4):234-237. PubMed ID: 28677168
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
[TBL] [Abstract][Full Text] [Related]
19. HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication.
Mackewicz CE; Garovoy MR; Levy JA
J Virol; 1998 Dec; 72(12):10165-70. PubMed ID: 9811757
[TBL] [Abstract][Full Text] [Related]
20. Selective Upregulation of CTLA-4 on CD8+ T Cells Restricted by HLA-B*35Px Renders them to an Exhausted Phenotype in HIV-1 infection.
Elahi S; Shahbaz S; Houston S
PLoS Pathog; 2020 Aug; 16(8):e1008696. PubMed ID: 32760139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
